Seems somebody forgot to mention that the "20% of allocation of institutional investors is for speculative stock" still represents tens of billions $$.
And do you really think insto's don't understand small aussie bio's?? If thats the case then the groups talking up this stock might also be wrong. Didn't Morgan's recently downgrade the projected sales..
- Forums
- ASX - By Stock
- AVR
- EACTS 2014
EACTS 2014, page-69
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.75 |
Change
-0.250(1.39%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $44.41K | 2.483K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 243 | $17.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.91 | 32 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 243 | 17.750 |
1 | 26 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
1 | 500 | 17.550 |
Price($) | Vol. | No. |
---|---|---|
17.910 | 32 | 2 |
17.930 | 51 | 2 |
17.940 | 26 | 2 |
17.950 | 270 | 2 |
18.000 | 518 | 2 |
Last trade - 13.43pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online